|
Session 13-Themed Discussion
TD: NeuroAIDS Treatment Issues and Controversies
Wednesday, 1-2 pm; Room 2010 |
429
 |
Higher CD4 Nadir Is Associated with Reduced Rates of HIV-associated Neurocognitive Disorders in the CHARTER Study: Potential Implications for Early Treatment Initiation
Ronald Ellis1, R Heaton1, S Letendre1, J Badiee1, J Munoz-Moreno1, F Vaida1, D Clifford2, B Gelman3, D Simpson4, I Grant1, and the CHARTER Group
1Univ of California, San Diego, US; 2Washington Univ in St Louis, MO, US; 3Univ of Texas Med Branch at Galveston, US; and 4Mt Sinai Sch of Med, New York, NY, US |
430
|
Correlates of Time-to-Loss-of-Viral-Response in CSF and Plasma in the CHARTER Cohort
Scott Letendre1, R Ellis1, R Deutsch1, D Clifford2, C Marra3, A McCutchan1, S Morgello4, D Simpson4, R Heaton1, I Grant1, and the CHARTER Group
1Univ of California, San Diego, US; 2Washington Univ in St Louis, MO, US; 3Univ of Washington, Seattle, US; and 4Mt Sinai Sch of Med, New York, NY, US |
431
|
No Decrease in Intrathecal Immunoactivation during Treatment Intensification in Patients on Stable ART
A Yilmaz, L Hagberg, B Svennerholm, and Magnus Gisslen
The Sahlgrenska Academy at Univ of Gothenburg, Sweden |
432
|
CSF Escape Is Uncommon in HIV-1-infected Patients on Stable ART
Arvid Edén1, R Price2, L Hagberg1, and M Gisslén1
1The Sahlgrenska Academy at Univ of Gothenburg, Sahlgrenska Univ Hosp, Sweden and 2Univ of California, San Francisco and San Francisco Gen Hosp, US |
433
|
Neuropsychological Performance Is Better in HIV-infected Subjects Treated with Neuroactive HAART
Fabrizio Starace, M de Stefano, A D’Abrosca, M Gargiulo, and A Chirianni
Cotugno Hosp, Naples, Italy |
434
|
cART Alters Changes in Cerebral Function Testing after 48 Weeks in Treatment-naïve, HIV-1-infected Subjects Commencing cART
A Winston1, C Duncombe2, P Li3, J Gill4, S Kerr2,5, Rebekah Puls5, K Petoumenos5, S Taylor-Robinson1, S Emery5, D Cooper5, and the Altair Study Group
1Imperial Coll London, UK; 2HIVNAT Res Collaboration, Bangkok, Thailand; 3Queen Elizabeth Hosp, Kowloon, Hong Kong; 4Calgary Regional Hlth Authority, Canada; and 5Univ of New South Wales, Sydney, Australia |
435
|
CNS Toxicity of Antiretroviral Drugs
J Liner, R Meeker, and Kevin Robertson
Univ of North Carolina at Chapel Hill, US |
|
